Human Embryonic Stem Cell Derived Retinal Pigment Epithelium (RPE) clinical trials

Interventional Study of Implantation of hESC-derived RPE in Patients With RP Due to Monogenic Mutation

This study is testing a new cell therapy for an inherited eye condition called retinitis pigmentosa (RP). Doctors are looking at the safety and how well special cells work in the eye to potentially improve or protect vision.